RESEARCH AREAS
Bioingénierie Tissulaire (BioTis)
Inserm U1026
Université Bordeaux
146, rue Léo-Saignat
33076 BORDEAUX cedex - France
Tél. : 33 (0)5 57 57 14 88
Fax : 33 (0)5 56 90 05 17
IN PROGRESS
Année 2016
HOP 182 Post-treatment F-18-FDG PET /CT predicts progression-free and cause-specific survival in patients with anal carcinoma. HOUARD C, VENDRELY V, PINAQUY JB, FERNANDEZ P, BORDENAVE L. J Nucl Med. 56 (3)Supplement: 3 2015, Meeting Abstract: 1345, View Journal Information, Conference: Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging; Baltimore, MD, 2015, Sponsor(s):Soc Nucl Med & Mol Imaging.
Année 2015
HOP 133 Evidence for the use of drug eluting stents in below-the-knee lesions. TROMBERT D, CARADU C, BRIZZI V, BERARD X, MIDY D, DUCASSE E. J Cardiovasc Surg (Torino). 2015, 56(1): 67-71.
HOP 134 A rare coronal fracture of the medial carpal column: Case report. DUNET B, VARGAS M, PALLARO J, TOURNIER C, T. Chirurgie de la main. 2015, 34(2): 94-7.
HOP 135 Acetabular component navigation in lateral decubitus based on EOS imaging: A preliminary study of 13 cases. BILLAUD A, VERDIER N, DE BARTOLO R, LAVOINNE N, CHAUVEAUX D, FABRE T. Orthopaedics & traumatology, surgery & research : OTSR. 2015, 101(3): 271-5.
HOP 136 The TASERed finger: A new entity. Case report and review of literature. DUNET B, ERBLAND A, ABI-CHAHLA ML, Tournier C, FABRE T. Chir Main. 2015,34(3) :145-8.
HOP 137 Evidence-based choice of dialysis technique in diabetics with end-stage kidney disease: half a loaf is better than no bread. COMBE C, RIGOTHIER C, CHAUVEAU P. Nephrology Dialysis Transplantation. 2015, 30(2) 160-162
HOP 138 Cytotoxic effects and cellular oxidative mechanisms of metallic nanoparticles on renal tubular cells: impact of particle solubility. PUJALTE I, PASSAGNE I, DACULSI R, DE PORTAL C, OHAYON-COURTES C, L'AZOU B. Toxicology Research 2015, 4(2): 409-422
HOP 139 Les lavages de nez et minéraux marins : Quels intérêts ? BASTIER P.L, LECHOT A, BORDENAVE L, DE GABORY L, Eur. Ann. Otorhinolaryngol 2015, 132(5) : 281-5.
HOP 140 Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study. BACHELET T1, NODIMAR C, TAUPIN JL, LEPREUX S, MOREAU K, MOREL D, GUIDICELLI G, COUZI L, MERVILLE P. Clin Transplant. 2015, 29(5):439-46.
HOP 141 Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. SICARD A, DUCREUX S, RABEYRIN M, COUZI L, MCGREGOR B, BADET L, SCOAZEC JY, BACHELET T, LEPREUX S, VISENTIN J, MERVILLE P, FREMEAUX-BACCHI V, MORELON E, TAUPIN JL, DUBOIS V, THAUNAT O. J Am Soc Nephrol. 2015, 26(2):457-67.
HOP 142 Cell-based flow cytometry crossmatch test discriminates effectively between pathogenic and non-pathogenipreformed dsa. BACHELET T, COUZI L, MARTINEZ C, VISENTIN J, GUIDICELLI G, LEPREUX S, TAUPIN L, MERVILLE P. Transplant International. 2015, 28(1): 1-1 Supplement: 1
HOP 143 heoretical attitudes versus actual practice patterns (MONITOR-CKD5 study). GESUALDO L, COMBE C, COVIC A, DELLANNA F, GOLDSMITH D, LONDON G, MANN JF, ZAOUI P, TURNER M, MUENZBERG M, MACDONALD K, ABRAHAM I. Int Urol Nephrol. 2015, 47(5):837-45.